Withaferin A
- Generic Name
- Withaferin A
Combination Therapy for Recurrent Ovarian Cancer
Phase 1
Recruiting
- Conditions
- Recurrent Ovarian Cancer
- Interventions
- First Posted Date
- 2022-11-09
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Sham Sunder Kakar
- Target Recruit Count
- 72
- Registration Number
- NCT05610735
- Locations
- 🇺🇸
UofL Health Brown Cancer Center, Louisville, Kentucky, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath